$OKLO

SpaceX vs. Oklo: Which Disruptive Stock Has More Upside?

SpaceX (SPCX) reported Q2 2026 revenue of $7.8B, up 92% YoY, but with a net loss of $541M and high capex. Oklo (OKLO) reported its first revenue of $1.2M in Q2 2026, with a net loss of $48.5M. SpaceX has a market cap of $1.76T, while Oklo's is $9B. Oklo offers more upside due to its smaller size, but SpaceX is less risky.

Original reporting
Published Aug 19, 2026, 11:51 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 20, 2026, 12:24 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
SpaceX vs. Oklo: Which Disruptive Stock Has More Upside? — source image
Decision brief

The 30-second read

$OKLONeutralLow
01

Why it matters

SpaceX's earnings are not included due to uncertain ticker; Oklo's first revenue report provides fresh data for traders.

02

Market read

Oklo's inaugural earnings introduce a new investment narrative in the nuclear‑energy sector.

03

What to watch

Regulatory approval timelines and potential cost overruns could delay revenue growth.

Relevance 9/10Novelty 8/10Timing: post‑earnings Aug 2026

Background

The article compares SpaceX and Oklo as disruptive stocks, focusing on their recent earnings releases.

Company-level read

Ticker impact

$OKLONeutralHigh confidence
Context

Oklo reported its first quarterly revenue of $1.2 million and a net loss of $48.5 million for Q2 2026.

Expected impact

Potential short‑term volatility with upside if deployment timeline improves.

Evidence & confidence

New primary earnings data for a listed micro‑cap; market will price in growth expectations versus current loss profile.

Market effects

Highlights emerging nuclear‑fission power segment within clean‑energy and AI‑energy demand themes.

Limited to US small‑cap investors; no broader regional effect.

Modest, as Oklo's technology could influence global nuclear‑energy discussions.

Counterpoint

Oklo's early losses and delayed commercial rollout may outweigh upside, suggesting caution.

Key entities

  • Oklo

    Developer of fast‑fission nuclear power plants.

Related articles

$OKLOMed

A Major Short Squeeze Could Be Brewing in Oklo Stock

Oklo (OKLO) may face a short squeeze as short interest remains high. The company reported $1.2M in Q2 revenue, beating estimates, but losses widened. Analysts see 94% upside potential, with a consensus price target of $81.55. Oklo's Aurora reactor is on track for 2028 commercial operation, but the stock is down 79% from its high.

$OKLOHighAI 9/10

Oklo Inc. Earnings Call Highlights Capital-Intensive Progress

Oklo Inc. Class A (OKLO) reported Q2 2026 earnings, highlighting the rapid commissioning of the Groves reactor, $3.0 billion in liquidity, and strategic partnerships. The company anticipates increased capital expenditures and operating cash use, with significant power revenue expected from 2028. Management emphasized technical progress and long-term deployment plans, despite near-term cash burn.

$OKLOMed

Aurora Advanced Nuclear Reactor by Oklo at INL Advances: First of its Kind in the U.S.

Oklo is advancing construction of its Aurora advanced nuclear reactor at Idaho National Laboratory, backed by $3.2B in funding. The project, supported by tech giants like Meta, aims to provide clean energy for data centers. Oklo is also planning a 1.2 GW campus in Ohio. The U.S. nuclear industry is gaining momentum, with Urenco expanding its uranium enrichment plant in New Mexico.

$OKLOMed

Sam Altman-backed OKLO Stock Drops As Q1 Loss Widens

Oklo (OKLO) shares fell about 3% after hours after the company reported a wider Q1 net loss of $33.1 million, or $0.19 per share, versus $9.8 million, or $0.07 a year earlier. Oklo also said it entered a strategic partnership with Battelle Energy Alliance for AI work tied to Idaho National Laboratory, and is moving into an NRC pre-application phase. JPMorgan set a neutral rating and $83 target; Tigress set Buy and $130.

$OKLOMed

Is Oklo a Millionaire Maker, or Is the Hype Overdone?

Oklo reported its first quarterly revenue for the quarter ended Aug. 7, generating $1.21 million versus none a year earlier, alongside a wider-than-expected net loss of about $48.5 million and operating expenses of about $74 million. The company said it has $3 billion in total liquidity and that its Groves Reactor reached first criticality. Oklo shares were up about 14% on the news.

$OKLOMed

Oklo Stock’s 14% Rally Leaves Investors Paying $6 Billion for Execution

Oklo Inc. (OKLO) shares rose 14.8% on Friday and 24.7% last week, though the stock is still down 32.5% in 2026. Q2 revenue was $1.2 million, mainly from acquired businesses, while net interest and dividend income was $23.2 million. A preliminary cash-adjusted valuation assigns about $6.0 billion to operations and future projects. Management cited Groves reaching first criticality and updated cash-use guidance.